Lead text placeholder. Lorem ipsum dolor sit amet, consectetur adipisicing elit.

 

  • A Phase 1b Multicenter, Open-Label Study to Determine the Safety, Pharmacokinetics, and Preliminary Efficacy of CC-99282 in Combination with Obinutuzumab in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • AN EXPLORATORY PHASE 1B OPEN-LABEL MULTIARM TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF CC-90009 IN COMBINATION WITH ANTI-LEUKEMIA AGENTS IN SUBJECTS WITH ACUTE MYELOID LEUKEMIA